We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Analysis of mortality and re-incarceration rates within 4 weeks of release for prison leavers receiving substance misuse treatment in England.
Summary Overview This report analyses the outcomes of prison leavers in…
Introduction This technical report describes the methodology we used to…
The following post holders were given pre-release access 24 hours before…
The report reviews the evidence on the use and harms of the novel benzodiazepine ethylbromazolam and recommends control under the Misuse of Drugs Act 1971.
1. Introduction 1.1. The Advisory Council on the Misuse of Drugs (ACMD)…
ACMD Chair: Prof David Wood ACMD NPS Committee Chair: Prof Simon Thomas…
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom.
Report produced in collaboration with Public Health Agency Northern…
The report presents a review of etomidate and structurally related compounds and subsequent recommendations regarding their classification and scheduling.
Statistics for alcohol and drug misuse treatment in prisons and other secure settings from the National Drug Treatment Monitoring System (NDTMS).
This report considers the use, harms and control of carisoprodol, a muscle relaxant previously prescribed in the UK to treat muscle spasms.
Following a 2025 government commission, the ACMD has carried out a review of the use and harms of ketamine.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Estimates of the number and rates of people using opiates and/or crack cocaine in England between April 2022 and March 2023.
An overview of the extent and trends of illicit drug use. Data are from the Crime Survey for England and Wales.
Alcohol and drug treatment data for children aged 17 and under, from the National Drug Treatment Monitoring System (NDTMS).
Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS).
Evaluation findings from the Department for Work and Pensions (DWP) test of Peer Mentoring for individuals with a substance dependency.
Estimates of the number and rates of people using opiates and/or crack cocaine in England between 2016 and 2020.
A report on the outcomes of the expansion of Individual Placement and Support (IPS) for adults in treatment for alcohol and drug dependence in England.
Updated and newly added indicators on the Fingertips ‘Co-occurring substance misuse and mental health issues profile’.
ACMD review into the use and harms of SSCs and THCA to identify compounds causing harm which are not captured by the current generic definition for cannabinoids.
A report outlining evidence and insights for Combating Drugs Partnerships, intending to help strengthen their preparedness for the synthetic opioid threat.
Report on the long-term prevention of drug use and related harms among young people.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).